Zdrowie i gospodarka · 19/05/2004

FDA Requests Public Comment on Patent Term Restoration Regulations

The Food and Drug Administration (FDA) is seeking public input on its patent term restoration regulations for due diligence petitions, which affect the regulatory review period for pharmaceutical products.